Tradeline, Inc. filters and categorizes new-construction and industry news from regional and professional journals across the country. Here you will find new projects, products, and regulatory updates.
Industry News
University of Hawaii Plans Biocontainment Lab
The University of Hawaii is planning to build the $47.5 Pacific Health Research Lab in Kalaeloa in West Oahu. The 31,000-sf facility will provide biocontainment laboratories for the study of emerging infectious diseases. The project will be a Regional Biosafety Laboratory and is supported by funding from the National Institute of Allergy and Infectious Diseases.
Gilead Sciences Plans Edmonton Research Facility
Gilead Sciences is planning to begin construction in early 2013 on a 45,000-sf research and development facility in Edmonton, Alberta. Located in the Eco Industrial Business Park, the three-story building will provide offices and laboratories for process chemistry and analytical drug discovery. The facility will be designed by Manasc Isaac Architects to accommodate 80 researchers.
Queen's University Belfast Builds Centre for Experimental Medicine
Queen's University Belfast is building the $51 million Centre for Experimental Medicine in the United Kingdom. The four-story facility will support research in genetics, diabetes, and degenerative eye diseases. The facility is located at Belfast City Hospital. Occupancy is expected in 2016.
Grand Valley State University Plans Biology Building
Grand Valley State University is planning to build a $55 million biology building in Allendale, Mich. Designed by Fishbeck, Thompson, Carr and Huber, the 144,000-sf facility will provide smart classrooms, teaching and research labs, and faculty offices. The laboratory programming and design consultant for the project is RFD (Research Facilities Design) and the construction manager is Pioneer Construction. Completion is expected in fall of 2015.
Eli Lilly Expands Pharmaceutical Manufacturing Campus
Eli Lilly will begin construction in late 2012 on a $140 million expansion of its Indianapolis pharmaceutical manufacturing campus. The 80,000-sf addition will support the production of insulin cartridges. Completion is expected in March of 2014 with operations beginning in 2015.